Compare MBIO & FLZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MBIO | FLZH |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 4.1M |
| IPO Year | 2023 | 2018 |
| Metric | MBIO | FLZH |
|---|---|---|
| Price | $0.55 | $0.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.0K | ★ 177.0K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.99 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,399,438.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.52 | $0.93 |
| 52 Week High | $1.84 | $2.88 |
| Indicator | MBIO | FLZH |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 14.17 |
| Support Level | $0.53 | N/A |
| Resistance Level | $0.66 | $1.85 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 24.12 | 0.07 |
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.